This is seismic,” said Dr. Colin Duckett, vice dean for basic and preclinical science at the Duke University School of ...

Dr. Varmus is a professor at Weill Cornell Medicine. He shared the 1989 Nobel Prize in medicine for the discovery of cancer ...

Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...

The No. 2 in command at the National Institutes of Health, Dr. Lawrence A. Tabak, who served as acting director of the agency ...

The University of Iowa is in danger of losing out on $33.4 million in research funding if National Institutes of Health ...

Here’s a look at what the Trump administration’s decision to cut overhead funding for biomedical research means for ...

Two key staff members at the National Institutes of Health (NIH) are reportedly leaving the agency amid ongoing efforts by ...

While the economic pain may not be as deeply felt as it might be at UAB and in Birmingham, NIH cuts will hurt UA and ...

The FDA approved brentuximab vedotin (Adcetris) in combination with lenalidomide (Revlimid) and rituximab for relapsed or ...

Dr. Lawrence A. Tabak, 73, has abruptly resigned from his post as acting director of the National Institutes of Health (NIH).

Private investment in pharmaceutical research can't replace the NIH. Both public investment and the private sector are needed ...

Washington University's leader on Thursday upped the alarm on proposed funding changes for National Institutes of Health ...